TDS - TNM Classification of Malignant Tumours

TNM Classification of Malignant Tumours

9th Ed.

James Brierley, MBBS, FRCP, FRCPSC, FRCR; Meredith Giuliani, MBBS, Med, PhD, FRCPC, DRCPSC; Brian O'Sullivan, MB, BCh, FRCPC, FRCPI, FFRRCSI (Hon); Brian Rous, MB, Bchir, MA, PhD, FRCPath; Elisabeth Van Eycken, MD

ISBN-13: 978-1-394-21685-7

eISBN-13: 978-1-394-21687-1

Oncology, Hematology

Description

The essential reference on cancer staging returns as a fully revised edition!

Describing cancer stage is one of the most important elements of oncological practice. Clinical research and clinical care depend on an accurate assessment of cancer stage and prognostic factors. The TNM Classification of Malignant Tumours serves as the globally recognized standard reference for describing cancer stage and assessing treatment results. Now fully updated to reflect the results of the latest clinical research, it is indispensable for all clinicians, cancer registrars and researchers who work with malignant tumours.

Readers of the ninth edition of TNM Classification of Malignant Tumours will find:

• Updates in many tumour sites including, nasopharynx, HPV associated oropharynx, lung, thymus, mesothelioma, appendix, anal canal, cervix, vulva and prostate carcinoma;
• Revised and updated sections on Essential TNM and paediatric cancer staging;
• New classifications for medulloblastoma, cutaneous lymphoma, parathyroid carcinoma, adrenal medulla and extra-adrenal paraganglia tumours;
• Revised classification of prognostic factors for many malignancies.

TNM Classification of Malignant Tumours is an essential resource for anyone involved in cancer care, research or cancer control.

Quotes, Reviews or Testimonials

"This is an update of the standard manual that has proven its value over the many years since it was first published... The seventh edition will be welcomed by all who have used the previous editions."

-- Ivan Damjanov, MD (University of Kansas Medical Center) Doody's Review - previous edition

"The material is therefore immediately applicable to patients worldwide, and not influenced by any particular healthcare system. The publication's greatest virtue continues to be its simplicity, distilling and arranging complex data in a way that is immediately applicable wherever cancer patients are seen."

-- (Knowledgespeak, December 2009) - previous edition

Audience

Intended for oncologists, surgeons, pathologists, and tumor registrars and it will be used by their trainees and assistants. The authors are well-known authorities in the field and have worked on most if not all previous editions of this manual.